Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
Targeting ROS in cancer: rationale and strategies
2024 Standout
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
2024 Standout
Works of Varun Monga being referenced
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
2022
Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Varun Monga | 356 | 339 | 250 | 264 | 80 | 1.0k | |
| J. Biau | 425 | 448 | 269 | 330 | 109 | 1.3k | |
| Wei Deng | 384 | 395 | 321 | 325 | 87 | 1.4k | |
| Tarek Assi | 390 | 325 | 90 | 167 | 84 | 872 | |
| Keigo Yorozu | 559 | 283 | 91 | 276 | 52 | 1.0k | |
| Yasuo Ejima | 369 | 386 | 103 | 328 | 49 | 1.3k | |
| Kazem Anvari | 266 | 206 | 202 | 390 | 73 | 913 | |
| Jayant Sastri Goda | 416 | 275 | 294 | 294 | 88 | 1.3k | |
| Michelangelo Russillo | 577 | 383 | 229 | 414 | 41 | 1.1k | |
| Sheau‐Chiann Chen | 575 | 366 | 124 | 351 | 74 | 1.4k | |
| Fable Zustovich | 310 | 517 | 204 | 289 | 87 | 922 |
All Works
Login with ORCID to disown or claim papers
Loading papers...